The risk of skin cancer in patients with alopecia areata is unknown.
There is a risk reduction in NMSC in alopecia areata patients compared to controls.
There is a trend towards melanoma risk reduction in this cohort versus controls.
Our results may provide insight into pathogenesis and treatment of both diseases.